DailyIQ
|
Sector:IndustrialsAll sectors
Last updated 7 minutes ago

IEX·IDEX Corporation

$.
+. (+.%)
After Hours
High
$223.58
Open
$220.50
Market Cap
16.49B
52W High
$230.18
Low
$219.61
P. Close
$222.22
P/E
32.48
52W Low
$157.25
Fwd P/E
24.07
DailyIQ Est.
$241.71
Technical Score (1D)
59
BUY
News Sentiment
79
BULLISH
IDEX reported Q1 revenue that beat estimates by 1.3%, driven by heightened demand from water‑conservation and carbon‑capture projects. The earnings beat signals that the company’s core demand remains resilient, suggesting it may sustain higher revenue in the near term. Traders should watch the forthcoming Q2 guidance for any updates on revenue and margin expectations, as it could confirm or adjust the current positive outlook. A Zacks upgrade to Buy, citing a stronger earnings outlook, reinforces market confidence and may influence analyst sentiment. The upgrade could lead to increased analyst coverage and potential inflows, so monitor any new research reports or target‑price revisions. Sector analysis shows IDEX’s margins are pressured by rising input costs, indicating potential compression in profitability. This cost pressure may affect the company’s ability to maintain margin expansion, so watch for any cost‑control initiatives or segment‑performance updates. The upcoming Q2 2026 earnings webcast on July 29 will provide early insights into segment performance and capital‑allocation plans. Finally, the low valuation score and stalled organic growth raise concerns about long‑term sustainability, so keep an eye on any strategic moves such as acquisitions or product‑pipeline developments.
Earnings Summary
IDEX Corporation is a global provider of applied solutions, operating across North America, Europe, Asia, and other international markets. The company's diverse portfolio is structured into three primary segments: Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products, serving a broad spectrum of industrial needs within the Industrials sector, specifically in Specialty Industrial Machinery. In its most recent reported quarters, IDEX Corporation demonstrated a mixed performance. For Q1 2026, the company reported an actual EPS of $2.00 against an estimate of $2.08797, and revenue of $886.9 million against an estimate of $888.5 million, indicating a miss on both metrics. This followed a Q4 2025 where actual EPS was $2.10 versus an estimate of $2.0636, and actual revenue was $899.1 million against an estimate of $891.25 million, showing a beat on both. Prior to this, Q3 2025 saw actual EPS of $2.03 against an estimate of $1.9303, and Q2 2025 reported actual EPS of $2.07 against an estimate of $1.98998, both representing beats. Historically, IDEX Corporation has shown a pattern of beating analyst estimates for EPS in three of the last four reported quarters (Q2 2025, Q3 2025, Q4 2025), with revenue estimates also being met or exceeded in the most recent periods where data is available. The company's trajectory shows consistent revenue generation, though EPS performance relative to estimates has varied, with a notable miss in the latest quarter. Recent news highlights IDEX Corporation's strategic focus on high-margin customers and products through a decentralized operating model and an 80/20 framework, with the Health & Science Technologies segment benefiting from secular tailwinds in the semiconductor industry. Management participation in the Oppenheimer 21st Annual Industrial Growth Virtual Conference and a raised price target from Seaport Global to $250 from $240 with a reiterated Buy rating signal positive analyst sentiment. Moving forward, investors will be watching for the company's ability to maintain its revenue growth momentum and how the Health & Science Technologies segment continues to perform amidst industry tailwinds. Key will be the company's performance in the upcoming quarter, particularly its ability to return to beating EPS estimates following the recent miss, and how its strategic initiatives translate into financial results.

EPS

EstBeatMiss
$1.57$1.72$1.87$2.03$2.18Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.11 - -
Q1'26$2.09$2.00-4.2%
Q4'25$2.06$2.10+1.8%
Q3'25$1.93$2.03+5.2%
Q2'25$1.99$2.07+4.0%
Q1'25$1.64$1.75+6.7%

Revenue

EstBeatMiss
$799M$832M$864M$897M$930MQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$915M - -
Q1'26$889M$887M-0.2%
Q4'25$891M$899M+0.9%
Q3'25 - $879M -
Q2'25 - $865M -
Q1'25 - $814M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

IEX Stock Snapshot

IEX is currently trading at $222.16, giving IDEX Corporation a market cap of 16.49B and a P/E ratio of 32.5. Today's range spans $219.61–$223.58, with shares opening at $220.50 and moving down $0.06 (0.0%) from the prior close. DailyIQ's technical score sits at 59/100 (HOLD) with a news sentiment reading of 79/100.

Over the past year IEX has traded between $157.25 and $230.18 - the current price is +41.3% off the 52-week low and -3.5% from the high. 22 analysts cover the stock with a Hold consensus and a mean 12-month target of $238.29 (range $210.00–$260.00), implying upside of +7.3%.

Sector rotation context matters for IEX's HOLD phase (59/100, HOLD): in Industrials, large-cap names (16.49B market cap) with neutral technicals and bullish sentiment (79/100) are often in a staging area ahead of a rotation trade. The current P/E ratio stands at 32.5. Price: $222.16 (near 52-week highs in $157.25–$230.18). When sector flows resume, names that consolidated cleanly rather than correcting sharply tend to lead the next leg - and IEX's current setup fits that pattern.

Portfolio construction in Industrials often uses large-cap names like IEX as tactical swing positions during neutral phases: cheap enough to overweight, liquid enough to exit quickly, and large enough to provide meaningful sector beta. The current 59/100 (HOLD) at $222.16 (near 52-week highs) and bullish sentiment (79/100) frame the position as a catalyst play within the $157.25–$230.18 annual range rather than a directional bet.